Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Statistically significant increase in growth rate at six months in SomatoKine study

July 23, 2004

PT-141 increases sexual behavior in female rats

July 23, 2004

6R-BH4 reported to decrease serum phenylalanine levels in PKU patients

July 23, 2004

Clinical improvements found with oxandrolone in HAE

July 22, 2004

Agonistic effects described for TAK-559 on different human PPAR subtypes

July 22, 2004

YAK3 inhibitors for hematopoietic diseases

July 22, 2004

Agreement on phase III program for eculizumab for PNH

July 22, 2004

ProSkelia claims vitronectin receptor antagonists

July 21, 2004

Novavax to reacquire rights to Estrasorb from King

July 21, 2004

AOP Orphan obtains Thromboreductin registrations in Central Europe

July 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...